CD47 and neoplasm: To evaluate our hypothesis, we inoculated C57BL/6 mice with SM1 melanoma cells (n = 9–12) and followed the experimental outline in Fig. 5A. The anti-CD47 antibody used in this study is clone miap301, which has been shown to partially exhibit tumor inhibition in syngeneic C57BL/6 mouse models [12].